Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $805,681 - $1.09 Million
6,799 New
6,799 $826,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $160,286 - $284,394
1,354 New
1,354 $243,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $5.76 Million - $12.6 Million
-25,972 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $3.37 Million - $6.1 Million
25,972 New
25,972 $6.1 Million
Q1 2019

May 15, 2019

SELL
$14.45 - $23.7 $830,875 - $1.36 Million
-57,500 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.52 - $18.8 $777,400 - $1.08 Million
57,500 New
57,500 $878,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.